# TISSUEBLUE

NDC: 68803-722
Generic name: Brilliant Blue G
Labeler / Manufacturer: D.O.R.C. Dutch Ophthalmic Research Center (International) B.V.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: INTRAOCULAR, OPHTHALMIC
Marketing started: 20191231

FDA application: NDA209569

## Active ingredients

- BRILLIANT BLUE G: .0125 mg/.5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68803-722"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68803-722
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9d4b28b4-c582-4e2c-abd9-f7e203378e2d